首页> Prostate cancer and prostatic diseases> Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy.

导出 OA

翻译打印收藏纠错

第一作者： Joseph,Marascio

第一单位： Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

作者： Joseph,Marascio ^[1] ; Daniel E,Spratt ^[2] ; Jingbin,Zhang ^[3] ; Edouard J,Trabulsi ^[4] ; Tiffany,Le ^[3] ; Worlanyo Sosu,Sedzorme ^[3] ; Whitney H,Beeler ^[2] ; Elai,Davicioni ^[3] ; Bashar,Dabbas ^[3] ; Daniel W,Lin ^[5] ; John L,Gore ^[5] ; Matthew,Bloom ^[1] ; Mark,Mann ^[4] ; J Ryan,Mark ^[4] ; Anne,Calvaresi ^[4] ; James L,Godwin ^[6] ; Peter,McCue ^[7] ; Mark D,Hurwitz ^[1] ; W Kevin,Kelly ^[6] ; Costas D,Lallas ^[4] ; Karen E,Knudsen ^[8] ; Leonard G,Gomella ^[4] ; Adam P,Dicker ^[1] ; Robert B,Den ^[9]

作者单位： Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. ^[1] Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. ^[2] Decipher Biosciences, San Diego, CA, USA. ^[3] Department of Urology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. ^[4] Department of Urology, University of Washington, Seattle, WA, USA. ^[5] Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. ^[6] Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. ^[7] Sidney Kimmel Cancer Center, Philadelphia, PA, USA. ^[8] Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. robert.den@jefferson.edu.;Department of Urology, Thomas Jefferson University Hospital, Philadelphia, PA, USA. robert.den@jefferson.edu.;Sidney Kimmel Cancer Center, Philadelphia, PA, USA. robert.den@jefferson.edu. ^[9]